Ocular Therapeutix (OCUL) Non Operating Income (2013 - 2026)

Ocular Therapeutix's Non Operating Income history runs 14 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• On a quarterly basis, Non Operating Income rose 3576.47% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a 21.36% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, up 118.77% from the prior year.
• Non Operating Income declined to $4.7 million in Q1 2026 per OCUL's latest filing, from $5.1 million in the prior quarter.
• Across five years, Non Operating Income topped out at $18.7 million in Q3 2023 and bottomed at -$33.2 million in Q1 2024.
• The 5-year median for Non Operating Income is -$112000.0 (2023), against an average of -$215117.6.
• Across the five-year window, Non Operating Income slumped 340.12% in 2023 and surged 3576.47% in 2026, its largest moves.
• Year by year, Non Operating Income stood at $3.8 million in 2022, then slumped by 340.12% to -$9.2 million in 2023, then soared by 123.86% to $2.2 million in 2024, then jumped by 133.36% to $5.1 million in 2025, then slipped by 7.4% to $4.7 million in 2026.
• Per Business Quant, the three latest OCUL Non Operating Income figures stand at $4.7 million (Q1 2026), $5.1 million (Q4 2025), and -$720000.0 (Q3 2025).